Table 2.
Cox proportional hazard regression analysis of factors associated with endoscopic remission in patients with CD.
| Univariate Cox Analysis | |||
|---|---|---|---|
| HR | 95% CI | p | |
| Sex (female vs. male) | 0.38 | 0.41–3.42 | 0.385 |
| Age at diagnosis | 1.07 | 0.84–1.37 | 0.583 |
| Any colonic involvement | 1.84 | 0.84–2.67 | 0.990 |
| Any upper gastrointestinal involvement | 1.60 | 0.25–10.29 | 0.619 |
| PCDAI at diagnosis | 1.00 | 0.98–1.02 | 0.942 |
| Erythrocyte sedimentation rate at diagnosis | 1.05 | 0.97–1.14 | 0.193 |
| Albumin at diagnosis | 3.49 | 0.08–120 | 0.514 |
| C-reactive protein at diagnosis | 0.41 | 0.07–2.45 | 0.326 |
| SES-CD at diagnosis | 1.00 | 0.84–1.01 | 0.078 |
| MTX vs. AZA | 0.71 | 0.13–3.90 | 0.691 |
HR, hazard ratio; CD, Crohn’s disease; PCDAI, Pediatric Crohn’s Disease Activity Index; SES-CD, simple endoscopic score for Crohn’s disease; MTX, methotrexate; AZA, azathioprine.